AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

The Medicines Company to Participate in the Bank of America Merrill Lynch 2019 Healthcare Conference

May 7, 2019

PARSIPPANY, N.J.--(BUSINESS WIRE)--May 7, 2019--The Medicines Company (NASDAQ:MDCO) announced that it will participate in the Bank of America Merrill Lynch 2019 Healthcare Conference on Tuesday, May 14, 2019, in Las Vegas. The Company is scheduled to present at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time).

A live audio webcast will be available on The Medicines Company Investor Relations website and a replay of the presentation will be available within 48 hours of the event.

About The Medicines Company

The Medicines Company is a biopharmaceutical company whose purpose is to halt the deadly progression of atherosclerosis and the cardiovascular risk created by high levels of LDL-C, or bad cholesterol. Our team is focused on transformational solutions that address the daily challenges that patients, physicians and payers confront in cardiovascular care. The Company is headquartered in Parsippany, New Jersey. For more information, please visit www.themedicinescompany.com and follow us on Twitter @MDCONews and LinkedIn.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190507005079/en/

CONTACT: Investor Relations

Krishna Gorti, M.D.

Vice President, Investor Relations

973 290 6122

krishna.gorti@themedco.comMedia Inquiries

Michael Blash

Vice President, Communications

973 290 6100

michael.blash@themedco.com

KEYWORD: UNITED STATES NORTH AMERICA NEVADA NEW JERSEY

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CARDIOLOGY PHARMACEUTICAL

SOURCE: The Medicines Company

Copyright Business Wire 2019.

PUB: 05/07/2019 07:00 AM/DISC: 05/07/2019 07:01 AM

http://www.businesswire.com/news/home/20190507005079/en